生物制剂治疗化脓性汗腺炎的研究进展
毛蒙蒙， 柏冰雪 - 中国麻风皮肤病杂志, 2021 - zgmfskin.com
… antibodyꎬ for patients with moderate-to-severe hidradenitis suppurativa[J]. Br J … Adalimumab
for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized …
for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized …
阿达木单抗生物类似药是否可进行临床互换用药: 基于系统评价与Meta 分析的证据
胡杨， 宋再伟， 高媛， 冉怡雯， 姜丹… - … 临床药理学与治疗学, 2024 - manu41.magtech.com.cn
… a multicenter, doubleblind, randomized, parallel-group study [J]. … adalimumab to CT-P17
(100 mg/ml): 52-week randomized, … in patients with hidradenitis suppurativa results in losses of …
(100 mg/ml): 52-week randomized, … in patients with hidradenitis suppurativa results in losses of …